This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: The Ohio State University, Phycotransgenics, LLC, Phyterra Bio Inc.. Active years: 2008-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Valdivia, CL (2008)
- Casilla, CL (2012)
Company Filing History:

Years Active: 2008-2012
Title: Innovations of Carlos Farias in Transgenic Algae
Introduction
Carlos Farias is an innovative inventor based in Casilla, Chile. He has made significant contributions to the field of biotechnology, particularly in the development of transgenic algae for delivering antigens to animals. With a total of 2 patents, his work focuses on enhancing immune responses through novel delivery systems.
Latest Patents
Farias's latest patent involves the use of transgenic algae to deliver biologically active proteins to host animals. The delivery systems and methods he developed include obtaining an algal cell transformed by an expression vector. This expression vector comprises a nucleotide sequence coding for the biologically active protein, which is operably linked to a promoter. In one embodiment, the biologically active protein is an antigenic epitope that, upon administration to the animal, induces an immune response.
Career Highlights
Throughout his career, Carlos Farias has worked with notable institutions such as The Ohio State University and Phycotransgenics, LLC. His experience in these organizations has allowed him to advance his research and contribute to the field of biotechnology.
Collaborations
Farias has collaborated with esteemed colleagues, including Richard Thomas Sayre and Richard E. Wagner. These partnerships have further enriched his research and innovation efforts.
Conclusion
Carlos Farias is a prominent inventor whose work in transgenic algae has the potential to revolutionize the delivery of antigens in veterinary medicine. His innovative approaches and collaborations continue to pave the way for advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile